Literature DB >> 18616877

Leukemic infiltration of the breast in acute lymphocytic leukemia (ALL).

Merat Karbasian-Esfahani1, Peter H Wiernik, Mrilini Yeddu, Lool Abebe.   

Abstract

Extramedullary leukemic infiltration of the breast in adult acute lymphocytic leukemia (ALL) is rare. We report two such cases here. One patient died of relapsed ALL and the other was cured with local radiation therapy and remains alive and in remission 30 years after relapsing in her breast. A literature review of reported cases of ALL with breast involvement is discussed.

Entities:  

Mesh:

Year:  2008        PMID: 18616877     DOI: 10.1179/102453308X315933

Source DB:  PubMed          Journal:  Hematology        ISSN: 1024-5332            Impact factor:   2.269


  6 in total

1.  Case of CML lymphoid blast crisis presenting as bilateral breast masses.

Authors:  Aneesha Hossain; Kanika Gupta; Andrew Mener; Imad Tabbara
Journal:  BMJ Case Rep       Date:  2016-08-10

2.  Differentiation of secondary involvement of the breast by lymphoreticular malignancy from fibroadenoma using ultrasound elastography: A report of two cases.

Authors:  Eren Abdulkadir; Ertan Gulhan; Sila Ulus
Journal:  Indian J Radiol Imaging       Date:  2017 Apr-Jun

3.  Relapse of Biphenotypic Acute Leukemia as a Breast Mass.

Authors:  Hee-Chul Shin
Journal:  J Breast Cancer       Date:  2016-12-23       Impact factor: 3.588

4.  Acute lymphoblastic leukemia presenting as a breast lump: A report of two cases.

Authors:  Syed Besina; Zubaida Rasool; Nuzhat Samoon; Othman Salim Akhtar
Journal:  J Cytol       Date:  2013-07       Impact factor: 1.000

5.  Granulocytic sarcoma of the breast in acute myeloid leukemia: Two case reports.

Authors:  Jianfei Fu; Jiansheng Luo
Journal:  Oncol Lett       Date:  2013-11-19       Impact factor: 2.967

6.  Isolated breast relapse mimicking breast cancer in elderly patient with acute lymphoblastic leukemia.

Authors:  Ajay Gogia; Prashant Mehta; Raja Pramanik; Rajive Kumar
Journal:  Turk J Haematol       Date:  2014-06-10       Impact factor: 1.831

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.